Matinas BioPharma Corporate Presentation 2023 | MTNB Investor

Matinas BioPharma presents its dual platform technology for therapeutic drug delivery using Lipid Nanocrystals and Phosphatidylserine Nanoparticles. The company's proprietary delivery systems target small molecules, oligonucleotides, and mRNA therapeutics with reduced toxicity and improved biodistribution. All product candidates are currently in development stage.